Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)—An eHealth intervention during chemotherapy.

Velikova, G orcid.org/0000-0003-1899-5942, Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L et al. (8 more authors) (2020) Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)—An eHealth intervention during chemotherapy. In: 2020 ASCO Annual Meeting I, 29 May - 01 Jun 2020, Online.